SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-030472
Filing Date
2014-05-14
Accepted
2014-05-14 16:30:43
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v377196_10q.htm 10-Q 517592
2 EXHIBIT 31.1 v377196_ex31-1.htm EX-31.1 10396
3 EXHIBIT 31.2 v377196_ex31-2.htm EX-31.2 10224
4 EXHIBIT 32.1 v377196_ex32-1.htm EX-32.1 3941
5 EXHIBIT 32.2 v377196_ex32-2.htm EX-32.2 3913
  Complete submission text file 0001144204-14-030472.txt   4428386

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20140331.xml EX-101.INS 579108
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20140331.xsd EX-101.SCH 51093
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20140331_cal.xml EX-101.CAL 37735
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20140331_def.xml EX-101.DEF 248899
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20140331_lab.xml EX-101.LAB 343940
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20140331_pre.xml EX-101.PRE 289700
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 14841949
SIC: 2834 Pharmaceutical Preparations